An affiliate of Peak Rock Capital announced that it has completed the acquisition of Asembia. Financial terms of the transaction were not disclosed.
Asembia is a provider of end-to-end technology-enabled commercialization solutions for the specialty pharmaceutical industry. The company serves pharmaceutical manufacturers, pharmacies, patients, and prescribers.
Asembia’s solutions include patient support HUB services, specialty distribution, data services, pharmacy software, and group purchasing solutions. The company also operates the Asembia Specialty Pharmacy Summit, a national specialty pharmacy conference that attracts thousands of industry leaders each year.
Peak Rock said the acquisition reflects its continued investment in high-growth founder-owned healthcare businesses. The firm plans to partner with the Irene family, Asembia management, and employees to support the company’s next stage of growth.
Peak Rock also plans to invest in technology, capabilities, marketing, and other growth initiatives. The firm said it will also pursue complementary acquisitions that can support accelerated growth.
Asembia is headquartered in Florham Park, New Jersey. Through its industry connectivity, stakeholder relationships, and tailored approach, the company helps improve therapy access and supports millions of patient experiences each year.
BofA Securities served as exclusive financial advisor to Asembia. McDermott Will & Schulte served as legal counsel to Asembia.
Houlihan Lokey served as financial advisor to Peak Rock. Kirkland & Ellis and Bass Berry & Sims served as legal counsel to Peak Rock.
Peak Rock Capital is a private investment firm focused on the middle market. The firm makes equity and debt investments in companies across North America and Europe.
KEY QUOTES:
“Asembia has a unique commitment to providing comprehensive technology enabled commercialization services across the specialty pharma value chain. We are excited to partner with the Irene family, Asembia management, and employees to invest in technology, capabilities, marketing, and other growth initiatives to support the company in serving more patients, prescribers, pharmacies, and pharma manufacturers. We plan to also pursue complementary acquisitions that will support accelerated growth.”
Spencer Moore, Managing Director of Peak Rock
“The investment from Peak Rock will help Asembia continue its mission of improving the experiences of patients, prescribers, and pharma and pharmacy partners to support patient care. With Peak Rock, Asembia will continue to make key investments in growth, technology, and innovation. We are excited to have Peak Rock’s support during the company’s next stage of growth.”
Lawrence Irene, Co-Founder and CEO of Asembia
“This transaction demonstrates Peak Rock’s considerable ongoing commitment to investing in founder-owned businesses with strong growth potential. It also highlights our continued interest in investing in resilient healthcare businesses and technology-enabled solutions that will benefit from our expertise in supporting transformational growth.”
Anthony DiSimone, CEO of Peak Rock
